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Abstract 
 
The syntheses of tetra-tetrazole macrocycles, containing two bis-tetrazole units linked by a variety 
of alkyl chain lengths from four to eight carbons, are described. The crystal structures of three of 
these derivatives are reported, and the molecular conformation in the solid state is compared to that 
of one previously reported tetra-tetrazole macrocycle and to other bis- and tris(tetrazole)benzene 
structures. The macrocycle conformation is influenced by the length of the alkyl chain linker, the 
relative orientation of the tetrazole rings on the benzene ring, and by intermolecular interactions. In 
the macrocycles based on 1,2-bis(tetrazole)benzene, the adjacent tetrazole rings on the benzene ring 
are prevented from becoming co-planar on intramolecular (steric) grounds. In the 1,3- and 1,4-
bis(tetrazole)benzene derivatives, there is no such impediment, and a co-planar arrangement is 
observed where intra- and/or intermolecular stacking interactions exist. Deviations from co-
planarity are associated with optimisation of intermolecular interactions between the tetrazole rings 
and adjacent alkyl chains. In the macrocycle based on 1,4-bis(tetrazole)benzene with four-carbon 
linkers, an intramolecular stacking interaction exists, which precludes the presence of any cavity. In 
the macrocycle based on 1,3-bis(tetrazole)benzene with six-carbon linkers, a cavity of 10.8 x 9.4 Å 
is observed for each molecule in the solid state, although the packing of adjacent molecules is such 
that there are no extended channels running through the crystal. 
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Introduction 
 
The growth of tetrazole chemistry over the last twenty-five years has been significant, mainly as a 
result of the roles played by tetrazoles in coordination chemistry as ligands, in medicinal chemistry 
as stable surrogates for carboxylic acids and in materials applications, including explosives and 
photography.
1
 The synthesis of tetrazoles by cycloaddition reactions between azides and nitriles is 
well documented.
2
 Recently, attention has been directed towards the use of polydentate aromatic 
nitrogen heterocycles, specifically ligands with five-membered rings, that is azoles. Tetrazoles 
exhibit a strong networking ability usually acting as mono- or bidentate ligands in most of the 
reported complexes.
3
 One possible application for these materials is in generating supramolecular 
arrays which embody additional functional groups capable of metal complexation. This would 
result in a metallotetrazole framework with possible potential as novel anti-microbial or therapeutic 
agents. Our interest in tetrazoles concerns their use as precursors for the formation of new 
functionalised poly-tetrazole macrocycles, which can find application, for example, as sensors or in 
molecular recognition. We have previously reported some preliminary synthetic steps concerning 
the addition of pendant short-chain alkyl halides, from dihaloalkanes, to some bis-tetrazoles.
4
 These 
reactions yield bis-tetrazole derivatives with pendant alkyl halide arms and also bis-tetrazole 
derivatives with pendant vinyl arms. We have also described the reactions of 1,4-
bis(tetrazole)benzenes with various long chain ,-dibromoalkanes.5 Butler and co-workers have 
synthesised both 1,2- and 1,3-bis(bromoalkyltetrazolyl)benzenes from N-unsubstituted tetrazoles 
and have succeeded in using these bis-(bromoalkyltetrazolyl)-benzenes to generate the tetra-
tetrazole macrocycle.
6
 The latter compound includes a cavity that can be tailored by both the length 
and flexibility of the alkyl chain and also by the substitution pattern on the benzene ring.
7
 In this 
paper, we describe the synthesis and characterisation of tetra-tetrazole macrocycles from 1,2-, 1,3- 
and 1,4-benzene derivatives, using short four-carbon, medium six-carbon and long eight-carbon 
alkyl linkers. The X-ray crystal structures of the 1,2- and 1,4-benzene derivatives with 4-carbon 
chain linkers are described, as well as the 1,3-benzene derivative containing the 6-carbon linker. 
Our principal focus is on the variation of the macrocycle cavity shape and dimensions through the 
series. 
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Results and Discussion 
 
Syntheses 
Butler and co-workers have described the synthesis of tetra-tetrazole macrocycles, based on either 
1,2- or 1,3-bis(tetrazol-5-yl)benzenes, with alkyl chains having either six or eight carbon chain 
linkers.
6
 We have extended this class of compounds by preparing macrocycles with four-carbon 
chain linkers, and also new macrocycles based on 1,4-bis(tetrazol-5-yl)benzene (Fig. 1). The 
syntheses were carried out in a manner similar to that described,
6
 by reacting 1,x-[bis(2-(y-
bromoalkyl)tetrazol-5-yl]benzene (x = 2, 3 or 4; y = 4, 6 or 8; alkyl = butyl, hexyl or octyl) with 
1,n-bis(tetrazol-5-yl)benzene (n = 2, 3 or 4) in dimethylformamide, using K2CO3 as base. 
Compounds 2, 3, 5 and 6 have been reported previously.
6
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Figure 1. Tetra-tetrazole macrocycles 
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In several of our reactions, carried out in relatively dilute conditions, two macrocyclic compounds 
were isolated, one containing all four tetrazole rings substituted at N-2, and the other containing 
three rings substituted at N-2 and the other one substituted at N-1, as reported previously.
6
 The 
macrocycles with all four tetrazole rings substituted in the same way will be designated hereafter 
with the suffix a, while those with one different substitution will be designated with the suffix b. 
 
In all reactions undertaken, on average 40% of the starting bis-tetrazole compounds were recovered. 
Extensive column chromatography, using a hexane/ethyl acetate mixture as eluent, was required to 
separate the product macrocycles from the starting materials and other intractable polymeric 
material. The isolated yields of the macrocyclic products were in the range 20-25%, which are 
comparable to those reported by Butler,
6
 and are reasonable for syntheses of this type. One possible 
reason for the low yields in these reactions is the potential to form polymeric chains between the 
two bis-tetrazole units, rather than macrocycles. Evidence that some polymeric chains were 
synthesised came from the fact that intractable material, which could not be dissolved in any solvent 
we tried, was obtained from all the reactions we attempted. The isomeric 1-N- and 2-N-tetrazole 
derivatives should be readily distinguishable from their respective 
1
H and 
13
C NMR spectra,
4,5a,6,8
 
with the 
13
C NMR chemical shift of the tetrazole carbon atom appearing at ca. 154.0 and 164.0 ppm 
in N-1 and N-2 substituted tetrazoles, respectively. Macrocycles containing four tetrazole rings all 
substituted at N-2 gave rise to only a single resonance at ~164.0 ppm, while both signals were 
apparent in the macrocycles containing tetrazole rings substituted at both N-1 and N-2. The high 
symmetry in the macrocycles containing four tetrazole rings substituted at N-2 also gave a 
corresponding decrease in the number of signals in the 
1
H NMR spectra compared to those 
substituted at both N-1 and N-2. 
 
X-Ray Crystal Stuctures 
We were able to obtain single crystals of the three symmetrical macrocycles 1a, 5a and 7a. The 
crystal structure of 2a has already been reported.
7
 Attempts to obtain suitable crystals of any of the 
unsymmetrical macrocycles have so far been unsuccessful. The molecular structures of 1a, 2a, 5a 
and 7a are shown in Figures 2, 3, 4 and 6 respectively. In each case, the molecule is 
centrosymmetric and is sited on a crystallographic centre of inversion. For comparison, in particular 
with regard to the orientations of the tetrazole substituents relative to the benzene ring, 16 further 
bis- and tris(tetrazole)benzene structures were identified in the Cambridge Structural Database 
(Version5.27 plus January, May and August updates; 388720 structures in total)
9
 and are listed in 
Table 1. 
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Table 1. 1,2-bis, 1,3-bis, 1,4-bis and 1,3,5-tris(tetrazole)benzene structures identified in the CSD. 
Compound CSD 
Refcode 
Dihedral angles between planes of 
tetrazole and benzene rings (º) 
Reference 
1,2-bis(tetrazole)benzenes    
 DEBSOS 34.1, 34.8 8 
 MARPOK 55.7, 55.7 10a 
 SADCUV 38.3, 58.5 10b 
 SADDAC 7.7, 85.6 10b 
 SARCEU 13.3, 83.7 4 
 ZUMWOT 47.9, 57.5 10c 
 ZUMWUZ 54.0, 56.6; 52.5, 66.6 10c 
1,3-bis(tetrazole)benzenes    
 DEBQUW 13.7, 13.7 8 
 FELZOM 29.4, 42.0 10d 
 FELZUS 14.7, 24.3; 10.1, 38.6 10d 
 SARCAQ 6.2, 8.8 4 
 ZUMXAG 8.3, 12.1 10c 
1,4-bis(tetrazole)benzenes    
 ICEGAZ 6.4, 6.4 10e 
 ICEGED 3.9, 3.9; 10.0, 10.0; 29.4, 29.4 10e 
1,3,5-tris(tetrazole)benzenes    
 HUKRUA 3.6, 4.7, 7.5 10f 
 TAWRIS 1.2, 22.4, 24.6,  10g 
 
The molecular structures of 1a (Fig. 2) and 2a (Fig. 3) are broadly comparable. One of the two 
unique tetrazole rings (containing N5-N8) lies close to coplanar with the benzene ring to which it is 
attached (dihedral angle between ring planes = 2.9 in 1a and 9.6 in 2a), while the other ring 
(containing N1-N4) is approximately orthogonal to it (dihedral angle between ring planes = 86.1 in 
1a and 82.5 in 2a). This arrangement eliminates potential repulsion between adjacent tetrazole 
rings (e.g. N1···N8) that would arise if they were coplanar. Comparable arrangements have been 
observed in two other 1,2-bis(tetrazole)benzene derivatives, namely SADDAC and SARCEU 
(Table 1). In all other 1,2-derivatives reported to date (Table 1), both tetrazole rings are twisted 
from the plane of the benzene ring, with dihedral angles in the range 34.1-66.6. 
 
In 1a and 2a, the planes of the benzene and tetrazole rings on opposite sides of the rectangular 
macrocycle (N5-N8 and its symmetry equivalent) are parallel. The four-carbon chain linkers in 1a 
adopt an approximately fully-extended conformation, with all four carbon atoms lying in the same 
plane. In 2a, five of the six carbons of the linker adopt a similar fully-extended conformation, while 
the sixth (C13) lies gauche with respect to the remainder of the chain (Fig. 3). Macrocycle 1a 
appears close to a regular rectangle, while 2a is sheared parallel to the long axis of the alkyl linker. 
The internal dimensions of the macrocycle (defined as the cross-macrocycle distances between the 
centroids of the tetrazole rings) are 9.7  5.3 Å in 1a, compared to 11.1  5.6 Å in 2a. Thus, the 
 8 
cross-macrocycle distance between the two co-planar tetrazole rings (5.3-5.6 Å) changes only 
slightly with variation of the chain linker. As noted by Butler et al.,
7
 space-filling representations of 
1a and 2a (Figs 2 and 3) show that the central “cavity” of the macrocycle is largely illusory, at least 
for the conformation observed in the solid state.  
 
 
 
Figure 2. Molecular structure of 1a showing displacement ellipsoids at the 50% probability level 
for non-H atoms (top), and a space-filling representation (bottom). 
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Figure 3. Molecular structure of 2a showing displacement ellipsoids at the 50% probability level 
for non-H atoms (top), and a space-filling representation (bottom).
7
 
 
In the structure of 5a (Fig. 4), both unique tetrazole rings remain close to coplanar with the benzene 
ring to which they are attached. The dihedral angle between the tetrazole and benzene ring is 25.2 
and 5.6º for N1-N4 and N5-N8, respectively. Comparison with other 1,3-bis(tetrazole)benzene 
structures (Table 1) shows that approximate co-planarity (considered to encompass the range 6.2 - 
14.7º) is common, and the structures of DEBQUW, SARCAQ and ZUMXAG show explicitly that 
there is no intramolecular impediment to approximate co-planarity of both rings. The moderate 
deviation from co-planarity for N1-N4 in 5a seems attributable, therefore, to optimisation of 
intermolecular contacts (see below) rather than any intramolecular feature. Similar to 2a, the six-
carbon chain linker in 5a exhibits an essentially fully-extended conformation for five of its six 
carbon atoms, while the sixth (C13) lies approximately gauche with respect to the remainder of the 
chain. The macrocycle geometry, in this case, is close to a regular square, with cross-macrocycle 
dimensions 10.8  9.4 Å. A space-filling representation of the structure (Fig. 4) shows that a 
genuine cavity is retained in the solid state.  
 10 
 
 
 
Figure 4. Molecular structure of 5a showing displacement ellipsoids at the 50% probability level 
for non-H atoms (top), and a space-filling representation (bottom). 
 
Adjacent macrocycles in 5a are arranged so that one benzene-tetrazole unit lies over the cavity of 
the adjacent macrocycle (Fig. 5a), forming a local stacking arrangement similar to that seen within 
7a (see below). On account of this packing arrangement, there are no extended channels running 
through the crystal. The interplanar separation between stacked benzene rings in this region is 3.68 
Å and the benzene centroid-to-centroid distance is 5.16 Å. A shorter contact of 4.05 Å exists 
between the centroid of the benzene ring and the centroid of one adjacent tetrazole ring (N5-N8). 
Involvement of the N5-N8 ring in this stacking interaction is consistent with its co-planarity with 
the benzene ring. In projection (Fig. 5b), the stacked macrocycles closely resemble 7a (Fig. 6). 
They are arranged in a herring-bone manner, which brings the tetrazole ring N1-N4 into the vicinity 
of an adjacent alkyl chain. The 25.2 twist of the tetrazole ring with respect to the benzene ring 
brings its mean plane parallel to that of the fully-extended section of the alkyl chain (C8-C12). 
Thus, the moderate twist of ring N1-N4 can be attributed clearly to optimisation of this 
intermolecular interaction. 
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Figure 5. (a) Stacking interaction between adjacent macrocycles in 5a. (b) Projection of 5a 
approximately along the a axis, showing the herring-bone arrangement, which brings tetrazole ring 
N1–N4 into close contact with an alkyl chain of the adjacent macrocycle. 
 
In 7a (Fig. 6), the four-carbon chain linkers permit an intramolecular stacking interaction, similar to 
that observed in macrocyclic systems such as bis(1,4-phenylene)crown ethers with ether chain 
linkers of appropriate length.
11
 The interplanar separation is 3.44 Å and the benzene centroid-to-
centroid distance is 3.91 Å. Clearly, this precludes the existence of any cavity within the 
macrocycle, and this interaction is likely to persist in solution. The tetrazole rings lie approximately 
co-planar with the benzene rings to which they are attached, forming dihedral angles 10.8 and 4.8º 
for the N1-N4 and N5-N8 rings, respectively, consistent with their participation in the stacking 
interaction. The approximately co-planar arrangement is most common in all previously examined 
1,4-bis(tetrazole)benzene structures (Table 1). Face-to-face stacking of 1,4-bis(tetrazole)benzene 
units is also observed between macrocycles for 7a in the solid state. The shortest additional contacts 
to the tetrazole ring are in-plane C–H···N interactions. 
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Figure 6. Molecular structure of 7a showing displacement ellipsoids at the 50% probability level 
for non-H atoms (top), and a space-filling representation (bottom). 
 
Conclusions 
 
In the solid state, the conformation of the macrocycle is influenced by the orientation of the 
tetrazole rings on the benzene ring, by the length of the alkyl-chain linkers and by intermolecular 
interactions. In the macrocycles based on 1,2-bis(tetrazole)benzene, the adjacent tetrazole 
substituents on the benzene ring are prevented from becoming co-planar on steric grounds. In both 
1a and 2a, the resulting conformation is such that no genuine cavity is retained. In the macrocycles 
based on 1,3- and 1,4-bis(tetrazole)benzene, there is no intramolecular impediment to co-planarity 
of the tetrazole rings with the benzene ring, and co-planarity is observed where stacking interactions 
are present. In 5a, these stacking interactions are intermolecular, while in 7a they are 
intramolecular. In the former case, one tetrazole ring is twisted slightly out of the plane of the 
benzene ring to which it is bound, apparently to optimise intermolecular interactions with an 
adjacent alkyl chain. In 7a, the intramolecular stacking interaction precludes the existence of any 
cavity, and this interaction is likely to persist in solution. In 5a, however, a genuine cavity of 
dimensions 10.8  9.4 Å is retained in the solid state, and appears feasible in solution. Currently, 
metal complexation reactions with this macrocycle are currently being investigated. We are 
interested in looking at both first row transition metal ions as well as some smaller alkali and 
alkaline earth metals, as metal ions from these groups using tetrazoles as ligands in coordination 
chemistry are described in the literature.
12
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Experimental 
 
1
H and 
13
C NMR (δ ppm; J Hz) spectra were recorded on a JEOL JNM-LA300 FT-NMR 
spectrometer using saturated CDCl3 solutions with Me4Si reference, unless indicated otherwise, 
with resolutions of 0.18 Hz and 0.01 ppm, respectively. Infrared spectra (cm
-1
) were recorded as 
KBr discs or liquid films between KBr plates using a Nicolet Impact 410 FT-IR. Melting point 
analysis was carried out using a Stewart Scientific SMP 1 melting point apparatus and are 
uncorrected. Mass spectra were carried out in the Mass Spectroscopy unit in the Centre for 
Synthesis and Chemical Biology, University College, Dublin. Microanalysis was carried out at the 
Microanalytical Laboratory of University College, Dublin. Standard Schlenk techniques were used 
throughout. Starting materials were commercially obtained and used without further purification. 
The synthesis of compounds 2a,
6b
 3a,
6b
 5a
6c
 and 6a
6c
 have been described in the literature 
previously. 
 
General Syntheses of tetra-tetrazolophanes 
 
A mixture of 1,n-bis(tetrazol-5-yl)benzene (1.1 mmol) and potassium carbonate (1.5 g, 11 mmol) in 
dimethylformamide (60 ml) was stirred for one hour at 75 C under an nitrogen atmosphere, and 
treated with 1,n-bis(2-(n-bromoalkyl)tetrazol-5-yl)]benzene (1.1 mmol) and stirred at 75 C for 24 
h. Insoluble salts, filtered from the cooled mixture, were washed with ethyl acetate and the 
combined washings and mother-liquor were evaporated under reduced pressure. The oily residue 
was chromatographed on silica gel using ethyl acetate : hexane (50 : 50) as eluent to give the 
cyclophane. All compounds were then recrystallised from chloroform. 
 
Di-orthobenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(4)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (1a). 
White solid. Analysis: Found: C, 54.02; H, 4.81; N, 41.42. Calc. For C24H24N16: C, 53.72; H, 4.51; 
N, 41.77; Yield: 33 mg, 12.3 %, 0.06 mmol; Rf 0.52 (50 : 50 hexane : ethyl acetate); M.p. 224–228 
C; νmax (KBr) 3150, 3090, 2955, 2828, 1724, 1500, 1499, 1467, 1440, 1391, 1359, 1285, 1178, 
1038, 787, 775, 730, 668 cm
-1
; H : 1.89 (m, 8 H, CH2), 4.64 (t, 8 H, J = 13.6 Hz, NCH2), 7.81 (m, 4 
H, Ar-H), 7.95 (m, 4 H, Ar-H); C : 29.1, 52.0 (tetrazole N2-CH2), 127.6, 130.3, 131.1, 164.5 (2,5-
tetrazole); HRMS (EI) Calc. 537.2448, Found 537.2422. 
 
Di-orthobenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(4)]-cyclophane (1-N, 2-N', 2-N'', 2-N''') (1b). 
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White waxy solid. Analysis: Found: C, 53.57; H, 4.84; N, 41.99. Calc. For C24H24N16: C, 53.72; H, 
4.51; N, 41.77; Yield: 22 mg, 8.2 %, 0.04 mmol; Rf 0.42 (50 : 50 hexane : ethyl acetate); νmax (KBr) 
3440, 2942, 2870, 1625, 1520, 1435, 1389, 1360, 1199, 1087, 1050, 910, 812, 787, 745, 692 cm
-1
; 
H : 1.91 (m, 6 H, CH2), 2.13 (m, 2 H, CH2), 4.64 (t, 2 H, J = 14.6 Hz, N
1
CH2), 4.77 (t, 6 H, J = 
13.6 Hz, N
2
CH2), 7.48 (d, 1 H, J = 6.6 Hz, Ar-H), 7.66 (t, 1 H, J = 13.0 Hz, Ar-H), 7.76 (d, 3 H, J = 
6.6 Hz, Ar-H), 8.37 (t, 3 H, J = 13.0 Hz, Ar-H); C : 29.0, 29.1, 46.6 (tetrazole N1-CH2), 52.6 
(tetrazole N2-CH2), 52.8 (tetrazole N2-CH2), 52.9 (tetrazole N2-CH2), 122.9, 127.2, 127.3, 127.5, 
129.4, 130.3, 130.6, 130.8, 131.1, 131.5, 154.1 (1,5-tetrazole), 162.7 (2,5-tetrazole), 163.1 (2,5-
tetrazole), 164.1 (2,5-tetrazole); HRMS (EI) Calc. 537.2448, Found 537.2437. 
 
Di-orthobenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(6)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (2a).6b 
White solid. Analysis: M.p. 178-180 C; Rf 0.50 (50 : 50 hexane : ethyl acetate); H : 1.37 (m, 8 H, 
CH2), 2.00 (m, 8 H, CH2), 4.59 (t, 8 H, J = 13.5 Hz, NCH2), 7.59 (m, 4 H, Ar-H), 7.91 (m, 4 H, Ar-
H). 
 
Di-orthobenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(6)]-cyclophane (1-N, 2-N', 2-N'', 2-N''') (2b). 
White solid. Analysis: Found: C, 56.96; H, 5.18; N, 37.86. Calc. For C28H32N16: C, 56.74; H, 5.44; 
N, 37.81; Yield: 49 mg, 18.2 %, 0.08 mmol; Rf 0.40 (50 : 50 hexane : ethyl acetate); M.p. 128–130 
C; νmax (KBr) 3435, 2925, 2858, 1629, 1555, 1450, 1359, 1275, 1198, 1049, 1099, 855, 746, 729, 
671 cm
-1
; H : 1.30 (m, 14 H, CH2), 1.75 (m, 2 H, CH2), 4.03 (t, 2 H, J = 14.2 Hz, N
1
CH2), 4.63 (t, 6 
H, J = 13.5 Hz, N
1
CH2), 7.48 (d, 1 H, J = 6.6 Hz, Ar-H), 7.66 (t, 1 H, J = 13.0 Hz, Ar-H), 7.73 (d, 3 
H, J = 6.6 Hz, Ar-H), 8.30 (t, 3 H, J = 13.0 Hz, Ar-H); C : 25.1, 25.3, 25.4, 25.5, 28.2, 28.6, 28.7, 
28.8, 47.1 (tetrazole N1-CH2), 52.5 (tetrazole N2-CH2), 52.7 (tetrazole N2-CH2), 53.4 (tetrazole 
N2-CH2), 122.8, 127.2, 127.5, 129.5, 130.0, 130.2, 130.3, 130.8, 131.5, 153.8 (1,5-tetrazole), 162.8 
(2,5-tetrazole), 164.1 (2,5-tetrazole), 164.1 (2,5-tetrazole); HRMS (EI) Calc. 593.3074, Found 
593.3100. 
 
Di-orthobenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(8)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (3a).6b 
White solid. Analysis: M.p. 148-150 C (lit. 147-148 C); Rf 0.53 (50 : 50 hexane : ethyl acetate); 
H : 1.35 (m, 12 H, CH2), 1.96 (m, 12 H, CH2), 4.57 (t, 8 H, J = 13.9 Hz, NCH2), 7.60 (m, 4 H, Ar-
H), 7.91 (m, 4 H, Ar-H). 
 
Di-orthobenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(8)]-cyclophane (1-N, 2-N', 2-N'', 2-N''') (3b). 
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White solid. Analysis: Found: C, 59.60; H, 6.41; N, 34.40. Calc. For C32H40N16: C, 59.24; H, 6.21; 
N, 34.54; Yield: 55 mg, 20.4 %, 0.08 mmol; Rf 0.40 (50 : 50 hexane : ethyl acetate); M.p. 146–148 
C; νmax (KBr) 3435, 2940, 2868, 1625, 1522, 1430, 1390, 1360, 1199, 1087, 1048, 910, 810, 787, 
745, 690 cm
-1
; H : 1.34 (m, 22 H, CH2), 1.72 (m, 2 H, CH2), 4.05 (t, 2 H, J = 14.6 Hz, N
1
CH2), 
4.55 (t, 6 H, J = 13.6 Hz, N
2
CH2), 7.48 (d, 1 H, J = 6.6 Hz, Ar-H), 7.66 (t, 1 H, J = 13.0 Hz, Ar-H), 
7.74 (d, 3 H, J = 6.6 Hz, Ar-H), 8.35 (t, 3 H, J = 13.0 Hz, Ar-H); C : 25.8, 25.9, 26.1, 26.1, 28.4, 
28.4, 28.5, 28.6, 28.6, 28.8, 29.1, 29.2,  47.3 (tetrazole N1-CH2), 52.8 (tetrazole N2-CH2), 52.8 
(tetrazole N2-CH2), 53.1 (tetrazole N2-CH2), 123.1, 127.4, 127.7, 129.5, 130.1, 130.4, 130.4, 130.5, 
130.8,  131.6, 153.9 (1,5-tetrazole), 162.9 (2,5-tetrazole), 164.1 (2,5-tetrazole), 164.3 (2,5-
tetrazole); HRMS (EI) Calc. 649.3700, Found 649.3679. 
 
Di-metabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(4)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (4a). 
White solid. Analysis: Found: C, 53.39; H, 4.43; N, 41.85. Calc. For C24H24N16: C, 53.72; H, 4.51; 
N, 41.77; Yield: 24 mg, 9.0 %, 0.04 mmol; Rf 0.50 (50 : 50 hexane : ethyl acetate); M.p. 284–286 
C; νmax (KBr) 3430, 2952, 2830, 1724, 1520, 1468, 1442, 1390, 1359, 1285, 1179, 1038, 787, 774, 
730, 667 cm
-1
; H : 1.89 (m, 8 H, CH2), 4.65 (t, 8 H, J = 13.5 Hz, NCH2), 7.63 (t, 2 H, J = 15.5 Hz, 
Ar-H), 8.27 (d, 4 H, J = 6.6 Hz, Ar-H), 8.82 (s, 2 H, Ar-H); C : 29.1, 52.0 (tetrazole N2-CH2), 
125.2, 128.2, 128.5, 129.6, 164.6 (2,5-tetrazole); HRMS (EI) Calc. 537.2448, Found 537.2452. 
 
Di-metabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(6)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (5a).6c 
White solid. Analysis: M.p. 150-152 C (lit. 150-152 C); Rf 0.52 (50 : 50 hexane : ethyl acetate); 
H : 1.37 (m, 8 H, CH2), 2.04 (m, 8 H, CH2), 4.67 (t, 8 H, J = 13.5 Hz, NCH2), 7.63 (t, 2 H, J = 6.5 
Hz, Ar-H), 8.27 (d, 4 H, J = 6.5 Hz, Ar-H), 8.82 (s, 2 H, Ar-H). 
 
Di-metabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(6)]-cyclophane (1-N, 2-N', 2-N'', 2-N''') (5b). 
White solid. Analysis: Found: C, 57.05; H, 5.20; N, 37.53. Calc. For C28H32N16: C, 56.74; H, 5.44; 
N, 37.81; Yield: 26 mg, 9.8 %, 0.04 mmol; Rf 0.40 (50 : 50 hexane : ethyl acetate); M.p. 148–150 
C; νmax (KBr) 3440, 2925, 2850, 1630, 1560, 1451, 1360, 1274, 1196, 1046, 1005, 854, 746, 730, 
669 cm
-1
; H : 1.26 (m, 8 H, CH2), 1.75 (m, 2 H, CH2), 4.48 (t, 2 H, J = 14.4 Hz, N
1
CH2), 4.67 (t, 6 
H, J = 13.5 Hz, N
2
CH2), 7.63 (t, 2 H, J = 6.6 Hz, Ar-H), 7.81 (d, 2 H, J = 6.6 Hz, Ar-H), 8.27 (d, 2 
H, J = 6.6 Hz, Ar-H), 8.83 (s, 2 H, Ar-H); C : 26.1, 26.2, 26.3, 26.4, 29.5, 29.5, 29.6, 29.7, 49.0 
(tetrazole N1-CH2), 53.8 (tetrazole N2-CH2), 53.9 (tetrazole N2-CH2), 54.0 (tetrazole N2-CH2), 
124.7, 125.3, 127.0, 128.6, 128.9, 129.2, 129.8, 129.9, 130.1, 130.5, 130.9, 154.1 (1,5-tetrazole), 
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162.8 (2,5-tetrazole), 164.3 (2,5-tetrazole), 165.0 (2,5-tetrazole); HRMS (EI) Calc. 593.3074, 
Found 593.3065. 
 
Di-metabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(8)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (6a).6c 
White solid. Analysis: M.p. 144-148 C (lit. 144-146 C); Rf 0.53 (50 : 50 hexane : ethyl acetate); 
H : 1.35 (m, 12 H, CH2), 1.96 (m, 12 H, CH2), 4.59 (t, 8 H, J = 13.6 Hz, NCH2), 7.63 (t, 2 H, J = 
6.6 Hz, Ar-H), 8.27 (d, 4 H, J = 6.6 Hz, Ar-H), 8.82 (s, 2 H, Ar-H). 
 
Di-metabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(8)]-cyclophane (1-N, 2-N', 2-N'', 2-N''') (6b). 
White solid. Analysis: Found: C, 59.45; H, 6.20; N, 34.35. Calc. For C32H40N16: C, 59.24; H, 6.21; 
N, 34.54; Yield: 24 mg, 9.0 %, 0.04 mmol; Rf 0.41 (50 : 50 hexane : ethyl acetate); M.p. 136–142 
C; νmax (KBr) 3436, 2938, 2860, 1623, 1520, 1433, 1390, 1358, 1199, 1087, 1045, 911, 810, 787, 
744, 691 cm
-1
; H : 1.23 (m, 22 H, CH2), 1.72 (m, 2 H, CH2), 4.48 (t, 2 H, J = 14.6 Hz, N
1
CH2), 
4.64 (t, 6 H, J = 13.5 Hz, N
1
CH2), 7.63 (t, 2 H, J = 6.6 Hz, Ar-H), 7.81 (d, 2 H, J = 6.6 Hz, Ar-H), 
8.27 (d, 2 H, J = 6.6 Hz, Ar-H), 8.83 (s, 2 H, Ar-H); C : 25.9, 26.0, 26.1, 26.1, 28.4, 28.4, 28.5, 
28.5, 28.6, 28.8, 29.1, 29.2, 47.3 (tetrazole N1-CH2), 52.8 (tetrazole N2-CH2), 52.8 (tetrazole N2-
CH2), 53.1 (tetrazole N2-CH2), 123.1, 124.8, 125.3, 127.4, 127.7, 129.5, 129.8, 129.9, 130.1, 130.5, 
130.9, 153.9 (1,5-tetrazole), 162.9 (2,5-tetrazole), 164.1 (2,5-tetrazole), 164.3 (2,5-tetrazole); 
HRMS (EI) Calc. 649.3700, Found 649.3688. 
 
Di-parabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(4)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (7a). 
White solid. Analysis: Found: C, 53.45; H, 4.41; N, 41.83. Calc. For C24H24N16: C, 53.72; H, 4.51; 
N, 41.77; Yield: 82 mg, 30.6 %, 0.15 mmol; Rf 0.52 (50 : 50 hexane : ethyl acetate); M.p. > 300 C; 
νmax (KBr) 3150, 3090, 2950, 2830, 1725, 1500, 1478, 1465, 1440, 1390, 1359, 1285, 1178, 1037, 
787, 770, 733, 665 cm
-1
; H : 2.09 (m, 8 H, CH2), 4.69 (t, 8 H, J = 13.5 Hz, NCH2), 7.97 (s, 8 H, Ar-
H); C : 29.7, 52.0 (tetrazole N2-CH2), 127.1, 129.6, 164.6 (2,5-tetrazole); HRMS (EI) Calc. 
537.2448, Found 537.2463. 
 
Di-parabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(6)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (8a). 
White solid. Analysis: Found: C, 56.45; H, 5.20; N, 37.95. Calc. For C28H32N16: C, 56.74; H, 5.44; 
N, 37.81; Yield: 84 mg, 31.3 %, 0.14 mmol; Rf 0.50 (50 : 50 hexane : ethyl acetate); M.p. 240–244 
C; νmax (KBr) 3150, 3090, 2924, 2860, 1623, 1450, 1379, 1281, 1205, 1125, 1075, 1048, 860, 746 
cm
-1
; H : 1.33 (m, 8 H, CH2), 2.04 (m, 8 H, CH2), 4.66 (t, 8 H, J = 13.8 Hz, NCH2), 8.17 (s, 8 H, 
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Ar-H); C : 25.3, 29.7, 52.8 (tetrazole N2-CH2), 127.3, 129.0, 164.6 (2,5-tetrazole); HRMS (EI) 
593.3074, Found 593.3088. 
 
Di-parabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(6)]-cyclophane (1-N, 2-N', 2-N'', 2-N''') (8b). 
Off-white solid. Analysis: Found: C, C, 56.40; H, 5.68; N, 37.45. Calc. For C28H32N16: C, 56.74; H, 
5.44; N, 37.81; Yield: 27 mg, 10.2 %, 0.05 mmol; Rf 0.39 (50 : 50 hexane : ethyl acetate); M.p. 
160–164 C; νmax (KBr) 3150, 3090, 2926, 2856, 1629, 1556, 1451, 1359, 1275, 1196, 1046, 1003, 
854, 746, 729, 670 cm
-1
; H : 1.30 (m, 8 H, CH2), 1.75 (m, 2 H, CH2), 1.86 (m, 4 H, CH2), 1.99 (m, 
2 H, CH2), 4.03 (t, 2 H, J = 14.5 Hz, N
1
CH2), 4.61 (t, 6 H, J = 13.6 Hz, N
2
CH2), 7.61 (m, 4 H, Ar-
H), 7.85 (d, 2 H, J = 6.6 Hz, Ar-H); 8.17 (s, 8 H, Ar-H), 8.38 (d, 2 H, J = 6.6 Hz, Ar-H); C : 25.1, 
25.3, 25.4, 25.5, 28.2, 28.6, 28.7, 28.8, 47.1 (tetrazole N1-CH2), 52.5 (tetrazole N2-CH2), 52.7 
(tetrazole N2-CH2), 53.4 (tetrazole N2-CH2), 129.1, 125.5, 122.8, 127.2, 127.5, 127.7, 129.5, 153.8 
(1,5-tetrazole), 162.8 (2,5-tetrazole), 164.1 (2,5-tetrazole), 164.1 (2,5-tetrazole); HRMS (EI) Calc. 
593.3074, Found 593.3057. 
 
Di-parabenzenotetra(5', 2'-tetrazolo)[5'-(2)-2'-(8)]-cyclophane (2-N, 2-N', 2-N'', 2-N''') (9a). 
White solid. Analysis: Found: C, 59.06; H, 6.18; N, 34.54. Calc. For C32H40N16: C, 59.24; H, 6.21; 
N, 34.54; Yield: 50 mg, 18.5 %, 0.08 mmol; Rf 0.53 (50 : 50 hexane : ethyl acetate); M.p. 284–286 
˚C; νmax (KBr) 3150, 3090, 2925, 2855, 1624, 1520, 1455, 1431, 1390, 1366, 1210, 1085, 1045, 
909, 786, 745, 690, 670 cm
-1
; H : 1.32 (m, 8 H, CH2), 1.36 (m, 8 H, CH2), 2.04 (m, 8 H, CH2), 4.62 
(t, 8 H, J = 13.3 Hz, NCH2), 8.25 (s, 8 H, Ar-H); C : 25.9, 28.5, 29.2, 53.2 (tetrazole N2-CH2), 
127.3, 129.1, 164.6 (2,5-tetrazole); HRMS (EI) Calc. 649.3700, Found 649.3720. 
 
X-Ray Crystallography 
Crystals of 1a, 5a and 7a suitable for X-ray analysis were obtained by recrystallisation from 
chloroform solution. Data were collected at 180(2) K on a Bruker Nonius X8 APEX II 
diffractometer,
12
 and a multi-scan correction was applied.
13
 The structures were refined against F
2
 
using all data.
14
 Hydrogen atoms were placed at calculated positions and refined using a riding 
model. 
 
Compound 1a. Crystal data: C24H24N16, M = 536.59, triclinic, a = 8.5805(3), b = 8.7679(4), c = 
9.4091(4) Å, α = 81.976(2),  = 70.235(2), γ = 66.642(2), U = 611.56(5) Å3, space group P-1, Z = 
1, μ(Mo-Kα) = 0.099 mm-1, calc = 1.457 g cm
–3
. 22917 data (2300 unique, Rint = 0.0243) were 
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measured in the range 4.07 < θ < 25.74˚. R1(I > 2σ(I)) = 0.0292 and wR2(all data) = 0.0740. 
Goodness of fit on F
2
 = 1.05. CCDC No. 633941. 
 
Compound 5a. Crystal data: C28H32N16, M = 592.70, monoclinic, a = 6.8210(6), b = 24.146(3), c = 
8.7297(10) Å,  = 96.924(4), U = 1427.3(3) Å3, space group P21/n, Z = 2, μ(Mo-Kα) = 0.092 mm
-
1
, calc = 1.379 g cm
–3
. 17057 data (2620 unique, Rint = 0.0600) were measured in the range 3.59 < θ 
< 25.43˚. R1(I > 2σ(I)) = 0.0441 and wR2(all data) = 0.1194. Goodness of fit on F
2
 = 1.01. CCDC 
No. 633942. 
 
Compound 7a. Crystal data: C24H24N16, M = 536.59, triclinic, a = 6.7596(12), b = 7.1970(12), c = 
12.9550(19) Å, α = 91.008(7),  = 100.326(6), γ = 100.409(6), U = 609.02(17) Å3, space group P-
1, Z = 1, μ(Mo-Kα) = 0.099 mm-1, calc = 1.463 g cm
–3
. 10192 data (2101 unique, Rint = 0.0602) 
were measured in the range 3.76 < θ < 25.14˚. R1(I > 2σ(I)) = 0.0716 and wR2(all data) = 0.2158. 
Goodness of fit on F
2
 = 1.11. CCDC No. 633943. 
 
Supplementary material 
 
Crystallographic data for 1a, 5a and 7a have been deposited with the Cambridge Crystallographic 
Data Centre, CCDC Nos. 633941-633943. Copies of this information may be obtained free of 
charge from deposit@ccdc.cam.ac.uk or www:http://www.ccdc.cam.ac.uk 
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